Bemiparin

Generic Name: Bemiparin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: -

CAS Number: 91449-79-5

Unique Ingredient Identifier: PUE0TO3XDR

Background: Bemiparin is an antithrombotic and belongs to the group of drugs known as the low molecular weight heparins (LMWH). Like semuloparin, bemiparin is classified as an ultra-LMH because of its low mean molecular mass of 3600 daltons, which is a unique property of this class . These heparins have lower anti-thrombin activity than the traditional low molecular wei...

Indication: Bemiparin is indicated in the following cases: To prevent blood clots in the veins after general abdominal surgery in patients with a moderate risk of venous thromboembolism; in the prevention of the thromboembolic disease in non-surgical patients; prevention of clotting in the extracorporeal circuit during hemodialysis; to prevent blood clots in the veins a...

Associated Conditions: Extracorporeal Clotting During Hemodialysis, Thromboembolism

Associated Therapies: Dialysis therapy

Clinical Trials

Comparison of Two Different Doses of Bemiparin in COVID-19

Phase 3

Conditions: COVID-19

Interventions: Drug: Bemiparin sodium

First Posted Date: 2020-10-27

Last Posted Date: 2020-10-27

Lead Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Target Recruit Count: 164

Registration Number: NCT04604327

Locations: 🇪🇸
Complejo Hospitalario de Navarra, Pamplona, Spain
🇪🇸
Complejo Hospitalario de Toledo, Toledo, Spain
🇪🇸
Hospital Clínico San carlos, Madrid, Spain

and more 9 locations

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Phase 2

Terminated

Conditions: Covid-19

Interventions: Drug: Bemiparin

First Posted Date: 2020-06-09

Last Posted Date: 2022-06-07

Lead Sponsor: Fundación de investigación HM

Target Recruit Count: 81

Registration Number: NCT04420299

Locations: 🇪🇸
Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain
🇪🇸
Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain

Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths

Early Phase 1

Completed

Conditions: Unexplained Stillbirth

Interventions: Other: multivitamins and routine antenatal follow up
Drug: Bemiparin

First Posted Date: 2018-07-26

Last Posted Date: 2018-12-10

Lead Sponsor: Hawler Medical University

Target Recruit Count: 140

Registration Number: NCT03601338

Locations: 🇮🇶
Hawler Medical University, Erbil, Kurdistan Region, Iraq

Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

Phase 3

Conditions: Cirrhosis and Coagulation

Interventions: Drug: Bemiparin

First Posted Date: 2016-06-16

Last Posted Date: 2016-06-16

Lead Sponsor: Instituto de Investigación Marqués de Valdecilla

Target Recruit Count: 225

Registration Number: NCT02802605

Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients

Not Applicable

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: Bemiparin
Drug: Enoxaparin

First Posted Date: 2016-06-09

Last Posted Date: 2016-06-10

Lead Sponsor: Mohamed Sayed Mohamed Abbas

Target Recruit Count: 100

Registration Number: NCT02795065

Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure

Phase 4

Completed

Conditions: Sterility

Interventions: Drug: Bemiparin sodium

First Posted Date: 2015-11-18

Last Posted Date: 2023-07-20

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 165

Registration Number: NCT02607319

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT

Phase 3

Completed

Conditions: Deep Vein Thrombosis

Interventions: Drug: Enoxaparin sodium
Drug: Bemiparin sodium

First Posted Date: 2013-06-18

Last Posted Date: 2016-02-04

Lead Sponsor: Berlin-Chemie AG Menarini Group

Target Recruit Count: 312

Registration Number: NCT01880216

Locations: 🇷🇺
St. Petersburg State Public Health Institution "City Multi-field Hospital #2", Saint-Petersburg, Russian Federation
🇷🇺
State Budget Public Health Institution of Yaroslavl region "Clinical hospital #10", Municipal Clinical Public Health Institution " Medical Unit of Novo-Yaroslavl Petroleum Refinery", Yaroslavl, Russian Federation
🇷🇺
State Budget Public Health Institution of Yaroslavl Region "Regional Clinical Hospital", Yaroslavl, Russian Federation

and more 22 locations